Brought to you by 
LabCorp and Celera Diagnostics ally on new genetic markers
13 Apr 2012
Executive Summary
Genetic testing company Celera Diagnostics will collaborate with clinical reference lab Laboratory Corp. of America to develop and validate the effectiveness of tests based on diagnostic markers for Alzheimer's disease, breast cancer, and prostate cancer.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
LabCorp and Celera Diagnostics ally on new genetic markers
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice